03:33 AM EDT, 04/03/2025 (MT Newswires) -- Sean Maduck, President, Corcept Endocrinology, on March 31, 2025, sold 100,590 shares in Corcept Therapeutics ( CORT ) for $10,121,594. Following the Form 4 filing with the SEC, Maduck has control over a total of 105,622 common shares of the company, with 85,622 shares held directly and 20,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1088856/000095017025049816/xslF345X05/ownership.xml